Related Experiment Video
Updated: Jul 6, 2026
09:48
Measuring Spinal Presynaptic Inhibition in Mice By Dorsal Root Potential Recording In Vivo
Published on: March 29, 2014
Spinal dis-inhibition in inflammatory pain
Hanns Ulrich Zeilhofer1, Ulrike B Zeilhofer
1Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. zeilhofer@pharma.uzh.ch <zeilhofer@pharma.uzh.ch>
Neuroscience Letters
|April 15, 2008
Summary
Inflammatory diseases cause chronic pain through signaling cascades. Restoring spinal GABAA receptor inhibition can reverse heightened pain sensitivity, offering a new therapeutic approach for hyperalgesia and allodynia.
Area of Science:
- Neuroscience
- Pain Research
- Pharmacology
Background:
- Inflammatory diseases and neuropathic insults trigger pain signaling.
- Chronic pain involves hyperalgesia, allodynia, and spontaneous pain.
- Synaptic plasticity and loss of inhibition in spinal dorsal horn neurons are implicated.
Purpose of the Study:
- To review mechanisms of synaptic dis-inhibition in inflammatory pain.
- To propose that restoring synaptic inhibition can reverse pathological pain sensitivity.
- To highlight the potential of targeting specific spinal GABAA receptor subtypes.
Main Methods:
- Review of existing literature on pain mechanisms.
- Analysis of synaptic plasticity and inhibitory control in pain pathways.
- Focus on GABAA receptor subtypes in spinal dorsal horn neurons.
Main Results:
- C-fiber long-term potentiation (LTP) contributes to hyperalgesia.
- Monosynaptic plasticity does not fully explain allodynia and spontaneous pain.
- Synaptic dis-inhibition is a key mechanism in inflammatory pain.
Conclusions:
- Pathologically heightened pain sensitivity can be reversed.
- Targeting specific spinal GABAA receptor subtypes offers a therapeutic strategy.
- Restoring synaptic inhibition is crucial for managing chronic pain syndromes.
Related Concept Videos
01:11Local Anesthetics: Clinical Application as Spinal Anesthesia
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
01:29Spasmolytic Agents: Chemical Classification
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
01:23Degenerative Disc Disease ll: Pathophysiology
The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...
01:28Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
01:24Local Anesthetics: Differential Sensitivity of Nerve Fibers
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
01:44Nociception
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...